-
Top 10 Chinese patent medicine plaster is out! 6 exclusive products stand out
Time of Update: 2022-12-04
In the first half of 2022, the top 10 plaster products of proprietary Chinese medicinesSource: Competition pattern of drug terminals in China's public medical institutions The product TOP10 market concentration is high, the total market share accounts for more than 70%, of which, 9 have sales of more than 100 million yuan, Yunnan white ointment ranks first, pain relief paste closely followed, both products are 1 billion yuan of large varieties, the first half of this year is again growth.
-
The first batch of inhaled new crown vaccines in Hangzhou was vaccinated
Time of Update: 2022-11-26
(End) On the 14th, the first batch of inhaled new crown vaccines in Hangzhou was first vaccinated at the Community Health Service Center of Wenhui Street, Gongshu, Hangzhou, which is also the first batch of inhaled new crown vaccines vaccinated in Zhejiang.
-
Shanghai will gather forces to build a digital health industry development ecosystem
Time of Update: 2022-11-26
At present, on the occasion of the "2022 Shanghai International Biomedical Industry Week", Liu Ping, deputy director of the Shanghai Municipal Economic Information Commission, revealed on the 15th th
-
TOP10 vaccine pharmaceutical companies have collected more than $100 billion, and the domestic market is chasing
Time of Update: 2022-11-26
In recent years, affected by the new crown epidemic, the global vaccine market has reached another peak. According to the annual report data of comprehensive pharmaceutical companies, the sales of th
-
According to the official notice, these county hospitals have been upgraded to the top three and equipped with a large number of equipment
Time of Update: 2022-11-26
According to incomplete statistics, the list of medical equipment necessary for upgrading to the third level of county hospitals is as follows (for reference only): Source: Medical Device Distributors Alliance In addition, the National Health Commission also said that in order to improve the capacity of emergency and critical treatment, county-level hospitals should accelerate the construction of five emergency emergency centers such as chest pain, stroke, trauma, critical maternal treatment, and critical child and newborn treatment.
-
Three insights of Jiangsu pharmaceutical centralized procurement: original research, hanging net and centralized procurement, and exclusive varieties
Time of Update: 2022-11-26
The two modes of volume procurement and hanging net have interpenetrated In addition, it is worth noting that the range of varieties collected this time also has a premise of "hanging the net", which may bring two market problems: First, varieties that are not listed on the net cannot participate in this collective procurement, of course, if the newly approved drugs are generally new 3/4 class chemicals, they are regarded as evaluations and are not included in this list.
-
Experts and the industry focus on digital medical innovation The prospect of personalized medicine is promising
Time of Update: 2022-11-26
enterprise Fan Jia hopes that through the sharing of this forum, it can promote the deep integration of digital technology in the medical and health field, accelerate the digital transformation process of Shanghai's medical industry, and benefit the people.
-
What is unique about the introduction of inhaled new crown vaccination in many places?
Time of Update: 2022-11-26
Inhaled vaccination has been launched in many places "Beijing Dongcheng" public account and "Beijing Shijingshan" public account news on the 15th, from now on, Beijing Dongcheng District and Shijingshan District can make an appointment to receive inhaled recombinant new coronavirus vaccine (type 5 adenovirus vector), which is currently only used for booster immunization.
-
Tens of billions of diabetes market, these 40 drugs best-selling (with list)
Time of Update: 2022-11-26
From 2015 to 2022, E has always ranked in the top 1 product in the terminal diabetes drug proprietary Chinese medicine market of China's urban physical pharmacies, and it is also the only product with sales of 100 million yuan, and the sales are expected to be more than 120 million yuan in 2022.
-
2022 Shanghai International Biomedical Industry Week opened
Time of Update: 2022-11-26
With the theme of "Helping the Future Together, All Things" and "Growing", this industry week consists of 1 opening event and nearly 40 concurrent activities, aiming to build a high-standard international exchange platform in the field of biomedicine, build an industrial activity brand with global influence, display global innovation achievements, share industry development trends, and promote enterprise cooperation and exchanges.
-
26 pharmaceutical and health industry projects landed in Beijing Changping, and the revenue is expected to exceed 72.5 billion yuan in 5 years
Time of Update: 2022-11-25
From the perspective of industrial track, the signed projects include major projects in key tracks with high-growth of cutting-edge technology, mainly including SINOVAC Kexing High-precision Achievement Transformation Base, Wantai Innovative Vaccine Industry Base, Zhuocheng Wison Advanced in Vitro Diagnostic Technology R&D and Transformation Base, Yangtze River Beijing Innovation Center, Kayudi POCT Molecular Diagnosis Production Base, Youbrain Galaxy Brain Science Achievement Research and Industrialization Project, Qi Hesheng Gene Editing Technology R&D Center, etc.
-
Get rid of the Red Sea fight API companies turned into CDMO
Time of Update: 2022-11-15
Pharmaceutical active materials (APIs), usually referred to as chemical APIs, are active ingredients in chemical pharmaceutical preparations. China is the world's largest API producer and exporter, w
-
Medical devices have become a new growth engine for giants, and third-party logistics has ushered in major new regulatory regulations
Time of Update: 2022-11-15
IVD quality management has special requirements The Appendix issued this time consists of 7 chapters and 48 articles, which put forward specific requirements for medical device third-party logistics enterprises from the aspects of establishment and improvement of quality management system, institutions and personnel, facilities and equipment, computer information systems and quality responsibilities.
-
The pharmaceutical province is coming! The 400 million market pattern will be reshaped
Time of Update: 2022-11-15
Sales of leuprolide injection, triptorelin injection and recombinant human coagulation factor VIII injection in public hospitals in Fujian Province (10,000 yuan)Source: Terminal competition pattern of public hospitals in key provinces and cities on the intranet It is worth mentioning that leuprolide injection and triptorelin injection are both analogues of gonadotropin-releasing hormone, which are mainly used for endometriosis, uterine fibroids, central precocious puberty and other diseases.
-
The landing of innovative drugs and devices benefits the well-being of the people and contributes to a healthy China
Time of Update: 2022-11-14
enterprises The genetic testing equipment manufacturer that has participated in the Expo for three consecutive years, the exhibits launched at the fourth CIIE have landed in more than 100 hospitals in China in the past year, and recently launched the first manufacturing base in China, planning to gradually realize the full local production of high-end gene sequencers and consumables in China in the next five years.
-
The electronic certification of "Certificate of API Export to the EU" and "Certificate of Export Sales of Drugs" is enabled
Time of Update: 2022-11-04
In order to thoroughly implement the major decisions and deployments of the Party Central Committee and the State Council on deepening the reform of "license separation", optimize the business enviro
-
Strong demand needs to be met The blue ocean value of the OTC hearing aid market is highlighted
Time of Update: 2022-10-25
In August, the U. S. Food and Drug Administration (FDA) issued a new over-the-counter (OTC) hearing aid regulation, announcing the creation of a new category of OTC hearing aids, effective October 17
-
A brief analysis of the development status of domestic linear accelerator and gamma knife subdivision
Time of Update: 2022-10-25
In China, unlike the medical linear accelerator market dominated by foreign brands, Gamma Knife is in the field of radiotherapy equipment, one of the subdivisions with the smallest gap between China's research and development technology and the international level, and the market share of domestic brands is relatively high.
-
19 varieties of more than $1 billion are on the road and other strikes
Time of Update: 2022-10-25
In 2021, the global sales exceeded 1 billion US dollars and there are no first imitation approved varieties in China Note: No sales or sales below 100 million yuan are represented by * Source: Intranet database Oimertinib Osimertinib is a third-generation oral, irreversible selective EGFR mutation inhibitor developed by AstraZeneca, which was first approved by the FDA in November 2015, and its global sales reached $5.
-
National Procurement Enlarged Moves! 257 drugs are at risk of "substitution"
Time of Update: 2022-10-21
A few days ago, the National Health Insurance Administration updated the reference monitoring scope list of the first seven batches of nationally sourced alternative drugs, aiming to strengthen the monitoring of clinical dosage and price changes of alternative drugs, and ensure the priority use of selected drugs in centralized procurement and the fairness of the online market.
